Structured evidence table for Resveratrol Exercise Performance Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Resveratrol Exercise Performance Randomized Trial | As a result, no phenotype-defined interventional evidence specific to sarcopenic obesity was identified. | 1 | Russo C (2026) | Vitamin D and resveratrol in sarcopenic obesity: a systematic review highlighting the gap in phenotype-defined randomized controlled trials. |
| Resveratrol Exercise Performance Randomized Trial | Conclusion Despite compelling mechanistic convergence, randomized interventional evidence in strictly defined sarcopenic obesity populations is currently lacking. | 1 | Russo C (2026) | Vitamin D and resveratrol in sarcopenic obesity: a systematic review highlighting the gap in phenotype-defined randomized controlled trials. |
| Resveratrol Exercise Performance Randomized Trial | Background Sarcopenic obesity (SO) is an inflammatory-metabolic condition characterized by the coexistence of excess adiposity and impaired skeletal muscle mass and function. | 1 | Russo C (2026) | Vitamin D and resveratrol in sarcopenic obesity: a systematic review highlighting the gap in phenotype-defined randomized controlled trials. |
| Resveratrol Exercise Performance Randomized Trial | Vitamin D and resveratrol modulate regulatory pathways implicated in SO pathophysiology, including NF-κB signaling, PGC-1α, mitochondrial regulation, and redox balance. | 1 | Russo C (2026) | Vitamin D and resveratrol in sarcopenic obesity: a systematic review highlighting the gap in phenotype-defined randomized controlled trials. |
| Resveratrol Exercise Performance Randomized Trial | Importantly, these biological changes manifest most meaningfully through declines in functional capacity, including reduced muscle strength, impaired metabolic regulation, diminished cognitive performance, and increased disease risk. | 4 | Kurtz Jennifer A. (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits |
| Resveratrol Exercise Performance Randomized Trial | This article aims to synthesize evidence from human studies evaluating dietary supplements that directly or indirectly modulate the recognized hallmarks of aging, such as mitochondrial dysfunction, oxidative stress, inflammation, and proteostasis. | 4 | Kurtz Jennifer A. (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits |
| Resveratrol Exercise Performance Randomized Trial | Rather than providing an exhaustive account of all supplements ever studied, this review focuses on representative compounds with the strongest or most emerging human evidence. | 4 | Kurtz Jennifer A. (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits |
| Resveratrol Exercise Performance Randomized Trial | Aging is a complex, multifaceted process marked by a gradual decline in physiological. | 4 | Kurtz Jennifer A. (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits |
Source documents